Bristol Myers Squibb plans $2.3B Houston campus
Bristol Myers Squibb is investing about $2.3 billion to build a roughly 600,000-square-foot, multi-modal manufacturing campus in Houston’s Generation Park, as part of its $40 billion five-year commitment to U.S. research, development, and domestic manufacturing. The facility will manufacture small molecules, biologics, and antibody-drug conjugates, using a modular design that can be expanded or reconfigured to match pipeline needs. The project is expected to create nearly 500 permanent skilled jobs and about 2,000 construction and related roles between 2027 and 2030. Texas officials have offered incentives, including a $4.89 million Texas Enterprise Fund grant and eligibility for additional programs, reflecting the state’s support for life sciences manufacturing. The company frames the investment as evidence of confidence in America’s leadership in biopharmaceutical innovation and its ability to scale operations to meet evolving patient needs. This move aligns with a broader industry push to expand U.S. manufacturing capacity amid policy and tariff considerations affecting pharmaceutical supply chains.
Where do you stand?
How it spread
Claim check
What each side asserts, disputes — or leaves out entirely.
Where do you land?
Whose framing of this story rings truest to you?
